BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Psilocybin (COMP360) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Psilocybin (COMP360)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07570654-855@assetmemo.bio
DTSTAMP:20261121T003053Z
DTSTART;VALUE=DATE:20281130
DTEND;VALUE=DATE:20281201
SUMMARY:Psilocybin (COMP360): Phase 2/3 readout est. (NCT07570654)
DESCRIPTION:Psilocybin (COMP360)\, phase 2/3\, Post-Traumatic Stress Disord
 er.\nStudy: Redefine Study: A Study Evaluating the Efficacy\, Safety\, and
  Tolerability of COMP360 in Participants With Post-traumatic Stress Disord
 er\nEstimated primary completion: November 2028. This is a ClinicalTrials.
 gov estimate\, not a confirmed readout date\, and it can move.\nDrug page:
  https://assetmemo.bio/drug/psilocybin-comp360#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07570654
URL:https://assetmemo.bio/drug/psilocybin-comp360#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06132178-855@assetmemo.bio
DTSTAMP:20261121T003053Z
DTSTART;VALUE=DATE:20291231
DTEND;VALUE=DATE:20300101
SUMMARY:Psilocybin (COMP360): Phase 2 readout est. (NCT06132178)
DESCRIPTION:Psilocybin (COMP360)\, phase 2\, Major Depressive Disorder.\nSt
 udy: Psilocybin rTMS for Treatment Resistant Depression\nEstimated primary
  completion: 31 December 2029. This is a ClinicalTrials.gov estimate\, not
  a confirmed readout date\, and it can move.\nDrug page: https://assetmemo
 .bio/drug/psilocybin-comp360#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT06132178
URL:https://assetmemo.bio/drug/psilocybin-comp360#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07226232-855@assetmemo.bio
DTSTAMP:20261121T003053Z
DTSTART;VALUE=DATE:20301202
DTEND;VALUE=DATE:20301203
SUMMARY:Psilocybin (COMP360): Phase 3 readout est. (NCT07226232)
DESCRIPTION:Psilocybin (COMP360)\, phase 3\, Major Depressive Disorder.\nSt
 udy: Psilocybin Intervention for Veterans Overcoming Treatment-Resistant D
 epression\nEstimated primary completion: 2 December 2030. This is a Clinic
 alTrials.gov estimate\, not a confirmed readout date\, and it can move.\nD
 rug page: https://assetmemo.bio/drug/psilocybin-comp360#upcoming-events\nR
 egistry record: https://clinicaltrials.gov/study/NCT07226232
URL:https://assetmemo.bio/drug/psilocybin-comp360#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
